BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 15708930)

  • 1. Immunopathology of psoriasis and psoriatic arthritis.
    Veale DJ; Ritchlin C; FitzGerald O
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii26-9. PubMed ID: 15708930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine targeting in psoriasis and psoriatic arthritis: beyond TNFalpha.
    MclInnes IB
    Ernst Schering Res Found Workshop; 2006; (56):29-44. PubMed ID: 16329645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis.
    Channual J; Wu JJ; Dann FJ
    Dermatol Ther; 2009; 22(1):61-73. PubMed ID: 19222518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis and psoriatic arthritis: clinical features and disease mechanisms.
    Myers WA; Gottlieb AB; Mease P
    Clin Dermatol; 2006; 24(5):438-47. PubMed ID: 16966023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New biologics for psoriasis and psoriatic arthritis.
    Rozenblit M; Lebwohl M
    Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.
    Candia L; Marquez J; Gonzalez C; Santos AM; LondoƱo J; Valle R; Zabaleta J; Yaqub Z; Espinoza LR
    J Clin Rheumatol; 2006 Oct; 12(5):226-9. PubMed ID: 17023808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenetic and clinical rationale for TNF-blocking therapy in psoriatic arthritis.
    Punzi L; Podswiadek M; Sfriso P; Oliviero F; Fiocco U; Todesco S
    Autoimmun Rev; 2007 Sep; 6(8):524-8. PubMed ID: 17854743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From skin to bone: translational perspectives on psoriatic disease.
    Ritchlin CT
    J Rheumatol; 2008 Jul; 35(7):1434-7. PubMed ID: 18609740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective new biologic therapies for psoriasis and psoriatic arthritis.
    Mortel MR; Emer J
    J Drugs Dermatol; 2010 Aug; 9(8):947-58. PubMed ID: 20684145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease.
    McGonagle D
    J Eur Acad Dermatol Venereol; 2009 Sep; 23 Suppl 1():9-13. PubMed ID: 19686380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriatic arthritis: update on pathophysiology, assessment and management.
    Mease PJ
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i77-84. PubMed ID: 21339225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all?
    McGonagle D; Benjamin M; Tan AL
    Curr Opin Rheumatol; 2009 Jul; 21(4):340-7. PubMed ID: 19424069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune regulation in psoriasis and psoriatic arthritis--recent developments.
    Hueber AJ; McInnes IB
    Immunol Lett; 2007 Dec; 114(2):59-65. PubMed ID: 17928070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriatic arthritis treatment: biological response modifiers.
    Mease PJ; Antoni CE
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii78-82. PubMed ID: 15708944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of psoriatic arthritis.
    Krueger GG
    Am J Manag Care; 2002 Apr; 8(6 Suppl):S160-70. PubMed ID: 11990861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
    Makredes M; Robinson D; Bala M; Kimball AB
    J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis and psoriatic arthritis: separate or one and the same?
    Ciocon DH; Kimball AB
    Br J Dermatol; 2007 Nov; 157(5):850-60. PubMed ID: 17725671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions.
    Helliwell PS; Taylor WJ;
    J Rheumatol; 2008 Mar; 35(3):472-6. PubMed ID: 18203324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide in psoriatic arthritis.
    Kaltwasser JP
    Autoimmun Rev; 2007 Sep; 6(8):511-4. PubMed ID: 17854740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy.
    Pomerantz RG; Mody E; Husni ME; Qureshi AA
    J Drugs Dermatol; 2009 Apr; 8(4):406-12. PubMed ID: 19363860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.